What question did this study set out to answer?

To evaluate the safety, clinical utility, and stump burst pressure of vessel-sealing devices compared with conventional ligation during thoracoscopic lobectomy for primary lung cancer.

June 3, 2014Interactive Cardiovascular and Thoracic SurgeryOpen Access

Usefulness of vessel-sealing devices for ≤7 mm diameter vessels: a randomized controlled trial for human thoracoscopic lobectomy in primary lung cancer

View Full Paper

Ask AI

Bookmark

Authors

MTMasayuki ToishiTowada City Hospital KYKazuo YoshidaToyama College HAHiroyuki Agatsuma

Discussion

Member takes

Implication

Randomized trial demonstrates reduced blood loss and drainage with vessel-sealing devices in thoracoscopic lobectomy, indicating safe pulmonary vessel closure.

Key Points

To evaluate the safety, clinical utility, and stump burst pressure of vessel-sealing devices compared with conventional ligation during thoracoscopic lobectomy for primary lung cancer.
Randomized trial allocating 58 primary lung cancer patients scheduled for thoracoscopic lobectomy with mediastinal lymph node dissection to conventional ligation (n=14) or vessel-sealing devices (n=44).
The intervention arm tested three distinct vessel-sealing devices on pulmonary artery branches ≤7 mm in diameter: EnSeal (n=17), LigaSure (n=15), and Harmonic (n=12).
Conventional ligation achieved higher stump burst pressures than vessel sealers (P < 0.0001), with <5-mm vessels tolerating greater pressure than ≥5-mm vessels (P = 0.0421), though all exceeded physiological pulmonary artery pressure.
Vessel-sealing devices significantly decreased intraoperative blood loss (P = 0.0241), surgeon stress via visual analogue scale (P = 0.0002), postoperative drainage volume (P = 0.0358), and drainage duration (P = 0.0449).
Operative time and endostapler cartridge usage did not differ significantly between groups, no significant differences emerged among the three individual devices, and zero perioperative deaths or severe complications occurred.

Cite This Study

Toishi et al. (2014) studied this question.

synapsesocial.com/papers/6aa9137b5ea9f476fd6c05f1 https://doi.org/10.1093/icvts/ivu176

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial demonstrates reduced blood loss and drainage with vessel-sealing devices in thoracoscopic lobectomy, indicating safe pulmonary vessel closure.

Usefulness of vessel-sealing devices for ≤7 mm diameter vessels: a randomized controlled trial for human thoracoscopic lobectomy in primary lung cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Usefulness of vessel-sealing devices for ≤7 mm diameter vessels: a randomized controlled trial for human thoracoscopic lobectomy in primary lung cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider